Skip to main content
Clinical Trials/NL-OMON48610
NL-OMON48610
Recruiting
N/A

Prospective Registration Of Critical Leg Ischemia Outcomes in the Netherlands - PROCLIO

Academisch Medisch Centrum0 sites502 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Academisch Medisch Centrum
Enrollment
502
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Critical limb ischemia is defined as following;
  • Patients must have ischemic rest pain, tissue loss, ulcer or gangrene. Symptoms
  • have to be present for more than two weeks at time of enrollment. PAD must be
  • confirmed by one of the following;
  • \* Absolute systolic ankle pressure \< 70 mmHg
  • \* Systolic Toe Pressure \< 50 mmHg
  • \* Transcutaneous oxygen pressure (tcPO2\) \< 50 mmHg
  • \* One or more significant (\>50%) obstructions in the iliac or lower limb
  • arteries as found with non\-invasive imaging (duplex ultrasonography (DUS),
  • Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA)) or

Exclusion Criteria

  • In the case of meeting any of the following criteria patients will be excluded
  • from enrollment.
  • \* Acute ischemia; due to emboli or trauma
  • \* Non\-atherosclerotic origin of ischemia; arteritis, thrombangitis obliterans
  • (Buerger\*s disease)
  • \* Hypercoagulable states
  • \* Venous ulcer
  • \* Insufficient proficiency of Dutch language, or inability to complete the
  • Dutch questionnaires
  • \* In the case of bilateral affected limbs, the least affected limb will be

Outcomes

Primary Outcomes

Not specified

Similar Trials